RxDoctor Payments Data

Patricia Booher

Nurse Practitioner · Humboldt, TNNPI 1417963570

Payments from drug & device makers

$8,603in general payments, 2019–2025

Across 433 payments — averaging $19.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Johnson & Johnson$2K
  • Incyte Corporation$526
  • Mayne Pharma Commercial LLC$446
  • Lilly USA, LLC$410
  • E.r. Squibb & Sons, L.L.C.$369
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$8,20495%
  • Education$3995%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,603 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$326,907
Medicare patients
2,011
Services billed
7,268

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa14$284,784
Humira PenAdalimumab12$81,410
Fluorouracil91$6,823
Ketoconazole183$2,595
Clindamycin Phosphate35$1,729
Betamethasone Dipropionate33$1,578
Triamcinolone Acetonide115$1,288
Doxycycline Hyclate61$1,246
Fluocinolone Acetonide24$1,130
Metronidazole24$961
Clobetasol Propionate22$755
ValacyclovirValacyclovir Hcl30$502
CiclopiroxCiclopirox Olamine13$496
Mupirocin56$344
Fluocinonide11$298

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Humboldt

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →